Nan Shan Life received regulatory business orders to suspend sales of investment-linked products until the quality of its new information technology (IT) system is reassured. We are extending our CreditWatch with negative implications on Nan Shan Life and its subsidiary Nan Shan General until we have greater clarity on progress in resolving Nan Shan Life's IT issues and the impact on the insurer's creditworthiness, particularly its business franchise and management culture. We expect to affirm the 'A-' ratings if we conclude that Nan Shan Life can effectively resolve the IT issues in the next three months and if we don't foresee further damage to the company's franchise, business, or financial strength. On Oct. 30, 2019, S&P Global Ratings kept its